Drug intelligence / Profile preview

heparinoid + escin + diethylamine salicylate

Development stage
Unknown
Lead developer
MADAUS
Modality
Small Molecules
Administration
Topical
01

Overview

This is a **topical combination drug** gel containing **heparinoid**, **escin**, and **diethylamine salicylate**. It is formulated for cutaneous application in the treatment of **sports-related and blunt impact injuries** (strains, sprains, contusions), as well as musculoskeletal pain and venous insufficiency. - **Heparinoids** possess anticoagulant and anti-inflammatory properties, improving local blood flow and preventing clot formation. - **Escin** (from horse chestnut seed extract) exerts anti-inflammatory, anti-edematous, and venotonic effects, mainly by stabilizing endothelial barriers and reducing microvascular permeability. - **Diethylamine salicylate** is a topical NSAID with analgesic, anti-inflammatory, and counterirritant actions, reducing musculoskeletal pain and inflammation. The gel demonstrates superior efficacy in reducing pain, tenderness, and swelling versus placebo and some single-ingredient comparators, with a rapid onset of symptom relief and a good safety profile[2][4][7].

02

Targets

COXHYAL (Hyaluronidase family (HYAL))

Beyond the preview

Go deeper on heparinoid + escin + diethylamine salicylate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on heparinoid + escin + diethylamine salicylate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call